Rest and exercise cardiovascular effects of terazosin in congestive heart failure

This study investigated the acute effects of the α 1 antagonist terazosin on myocardial circulatory responses at rest and during exercise. Ten patients with congestive heart failure (class III and IV) underwent hemodynamic evaluation before and after a 5-mg oral dose of terazosin. At rest and during...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of cardiology 1990-03, Vol.65 (9), p.638-643
Hauptverfasser: Magorien, Raymond D., Sinnathamby, Sukirtharan, Leier, Carl V., Boudoulas, Harris, Unverferth, Donald V.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This study investigated the acute effects of the α 1 antagonist terazosin on myocardial circulatory responses at rest and during exercise. Ten patients with congestive heart failure (class III and IV) underwent hemodynamic evaluation before and after a 5-mg oral dose of terazosin. At rest and during exercise, terazosin significantly decreased pulmonary capillary wedge pressure, systemic vascular resistance and mean arterial pressure while cardiac index increased. Stroke volume index increased (p < 0.01) during exercise while left ventricular stroke work index remained unchanged in both experimental conditions. Terazosin administration significantly decreased both rest and exercise myocardial oxygen consumption while exercise coronary sinus oxygen content increased and arterial-coronary sinus oxygen difference diminished (p < 0.05). Parallel with these changes, a blockade decreased the ratio of coronary blood flow to total cardiac output. Coronary vascular resistance remained unaltered with a blockade both at rest and during exercise. Coronary blood flow tended to diminish with decreased myocardial oxygen demand. Alpha 1 blockade induces systemic vasodilation and improves myocardial circulatory parameters with-out inducing coronary dilation or altering metabolic autoregulation.
ISSN:0002-9149
1879-1913
DOI:10.1016/0002-9149(90)91044-7